Antenatal corticosteroids to reduce neonatal morbidity and mortality Flashcards
Antenatal steroids - benefit
Given within 7 days prior to PTB reduces perinatal and neonatal death and respiratory distress syndrome
Reduces neonatal death when the first dose is given within the 48 hours prior to birth, benefit also seen when given <24h of birth
Antenatal steroids - Caesarean birth 37+0 to 38+6
Discuss risk risks/ benefits
May reduce admission to NICU for respiratory morbidity
Uncertain if any reduction in respiratory distress syndrome, transient tachypnoea of the newborn or neonatal unit admission overall
May result hypoglycaemia and potential developmental delay in neonate
Antenatal steroids - when to offer
24+0 to 34+6 weeks in whom PTB is anticipation (established PTL, PPROM, planned PTB)
Antenatal steroids - multiple pregnancy
Offer targeted antenatal corticosteroids for early birth in line with recommendations for singletons
Antenatal corticosteroids - 22+0 to 34+6 - BENEFITS
Highly likely to reduce
- Perinatal mortality
- Neonatal death
- Neonatal respiratory distress
Likely to reduce
- Intraventricular haemorrhage
- Developmental delay
Most likely seen if 24-48h prior to birth
Reduction in respiratory morbidity (NOT mortality or IVH) if birth <7 days of treatement
Antenatal corticosteroids - 22+0 to 34+6 - HARMS
Likely to: Affect maternal BMs (up to 5 days)
Reduce BW if birth >7 days after
No benefits likely to be seen if birth >7 days after
MAY increase psychiatric and behavioural diagnoses if children born at term
Antenatal corticosteroids - 35+0 to 36 - BENEFITS
Likely to: reduce respiratory support
Antenatal corticosteroids - 35+0 to 36 - HARMS
Likely to: increase neonatal hypoglycaemia
May increase psychiatric and behavioral diagnoses if children born at term
Antenatal corticosteroids - before plan CS at 37-39 weeks - BENEFITS
May decrease admission to NNU with resp morbidity
Antenatal corticosteroids - rescue course if treatment >7 days ago - BENEFITS
Likely to reduce respiratory spport
Antenatal corticosteroids - before plan CS at 37-39 weeks - HARMS
May reduce educational attainment at school age
Antenatal corticosteroids - rescue course if treatment >7 days ago - HARMS
Likely to reduce birthweight, head circumference and neonatal BP
Antenatal corticosteroids - in GDM
Maternal blood glucose risk after administration for up to 5 days
Diabetes should not be considered a contraindication to antenatal corticosteroids for fetal lung maturation (NICE)
Antenatal corticosteroid administration in GDM
Insulin-treated diabetes - additional insulin should be given according to an agreed protocol and the women should be monitored closely
Antenatal corticosteroids - in hypertensive disorders
Offer if planned early birth for hypertension in pregnancy (NICE) - but do not delay birth for steroids
Cochrane Systematic Review
- No differences in corticosteroid effects on perinatal mortality, neonatal mortality and fetal death seen between women with and without hypertension syndromes
- Subgroup analyses = potentially a larger reduction in RDS seen in hypertensive mothers than other groups (uncertain)